ADC Therapeutics SA (ADCT)
1.29
-0.01
(-0.77%)
USD |
NYSE |
Sep 09, 13:52
ADC Therapeutics Max Drawdown (5Y) : 99.08% for Aug. 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| August 31, 2026 | 99.08% |
| July 31, 2026 | 99.08% |
| June 30, 2026 | 99.08% |
| May 31, 2026 | 99.08% |
| April 30, 2026 | 99.08% |
| March 31, 2026 | 99.08% |
| February 28, 2026 | 99.08% |
| January 31, 2026 | 99.08% |
| December 31, 2025 | 99.08% |
| November 30, 2025 | 99.08% |
| October 31, 2025 | 99.08% |
| September 30, 2025 | 99.08% |
| August 31, 2025 | 99.08% |
| July 31, 2025 | 99.08% |
| June 30, 2025 | 99.08% |
| May 31, 2025 | 99.08% |
| April 30, 2025 | 99.08% |
| March 31, 2025 | 99.08% |
| February 28, 2025 | 99.08% |
| January 31, 2025 | 99.08% |
| December 31, 2024 | 99.08% |
| November 30, 2024 | 99.08% |
| October 31, 2024 | 99.08% |
| September 30, 2024 | 99.08% |
| August 31, 2024 | 99.08% |
| Date | Value |
|---|---|
| July 31, 2024 | 99.08% |
| June 30, 2024 | 99.08% |
| May 31, 2024 | 99.08% |
| April 30, 2024 | 99.08% |
| March 31, 2024 | 99.08% |
| February 29, 2024 | 99.08% |
| January 31, 2024 | 99.08% |
| December 31, 2023 | 99.08% |
| November 30, 2023 | 99.08% |
| October 31, 2023 | 98.72% |
| September 30, 2023 | 98.59% |
| August 31, 2023 | 97.71% |
| July 31, 2023 | 97.57% |
| June 30, 2023 | 96.28% |
| May 31, 2023 | 96.28% |
| April 30, 2023 | 96.24% |
| March 31, 2023 | 96.24% |
| February 28, 2023 | 94.38% |
| January 31, 2023 | 94.38% |
| December 31, 2022 | 94.38% |
| November 30, 2022 | 93.38% |
| October 31, 2022 | 91.95% |
| September 30, 2022 | 90.87% |
| August 31, 2022 | 88.33% |
| July 31, 2022 | 88.33% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Basilea Pharmaceutica AG | 55.70% |
| Santhera Pharmaceuticals Holding AG | 98.31% |
| BeOne Medicines Ltd. | 69.96% |
| AC Immune SA | 89.55% |
| CRISPR Therapeutics AG | 85.11% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -67.88 |
| Beta (5Y) | 1.843 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 124.8% |
| Historical Sharpe Ratio (5Y) | -0.4098 |
| Historical Sortino (5Y) | -0.9997 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.86% |